NanoBio Gets $6 Million Grant From Gates Foundation For RSA Vaccine
ANN ARBOR - NanoBio Corporation announced Tuesday that it has received a $6 million grant from the Bill & Melinda Gates Foundation to support the development of a safe and effective intranasal vaccine for Respiratory Syncytial Virus, a highly contagious viral disease and is one of the most common causes of bronchiolitis and pneumonia. RSA